rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Shannon Thyme Klinger

Chief Legal Officer

Company insider

Files Form 4 as: Chief Legal Officer, Moderna; Director, Rafael Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
248
Buys
0
Sells
28
Bought
$0
Sold
$4.9M
Companies
2
Companies where not an officer
1
First trade
7 Jun 2021
Last trade
4 Sep 2026
Last filed
8 Sep 2026

Companies traded

Where they are an officer
MRNA ModernaOfficer · Biotechnology · last 4 Sep 20260 buys · 28 sells
Everywhere else they filed: board seats, 10% stakes, other companies
RFL Rafael HoldingsDirector · Biotechnology · last 5 Jan 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Sep 2026filed 8 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—11,797filing
4 Sep 2026filed 8 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code F$849K5,704 at $148.87filing
4 Sep 2026filed 8 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—11,797 at $0.00filing
4 Sep 2026filed 8 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—11,797 at $0.00filing
4 Sep 2026filed 8 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—11,797filing
4 Sep 2026filed 8 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code F$849K5,704 at $148.87filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$107K3,471 at $30.96filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$486K3,471 at $139.95filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—2,166filing
1 Sep 2026filed 3 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—3,471 at $0.00filing
1 Sep 2026filed 3 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—2,166 at $0.00filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code F$147K1,048 at $140.34filing
1 Sep 2026filed 3 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—3,471 at $0.00filing
1 Sep 2026filed 3 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—2,166 at $0.00filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$107K3,471 at $30.96filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$486K3,471 at $139.95filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—2,166filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code F$147K1,048 at $140.34filing
28 Aug 2026filed 31 Aug 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—329filing
28 Aug 2026filed 31 Aug 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—329 at $0.00filing

Sectors

Health Care28

Buys in green, sells in red, by the company’s sector.

Related people

Stephen HogePresident · President at Moderna, filing Form 4 there in the last year
James M. MockChief Financial Officer · Chief Financial Officer at Moderna, filing Form 4 there in the last year
Stephane BancelChief Executive Officer · Chief Executive Officer at Moderna, filing Form 4 there in the last year
Michael R. McDonnellDirector · Director at Moderna, filing Form 4 there in the last year
Soria Ester BanqueChief Commercial Officer · Chief Commercial Officer at Moderna, filing Form 4 there in the last year
Maria Elvira SalazarRepresentative, FL-27 · Also traded MRNA in the last 90 days
Donald J. TrumpPresident · Also traded MRNA in the last 90 days